Senior insider sale
Chief Development Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.62M
39.76K shares
What this filing means
PIZZUTI DANA plans to sell 39.76K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $1.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/18/2026ACC: 0001950047-26-002789
Officer· Chief Development Officer
Since Sep 2022
39.76K
Shares to sell
$1.62M
Approx. market value
24.76K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
3/18/2026
15KRestricted Stock Units
N/A
3/15/2026
9.76KTotal acquired24.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/18/2026 | Exercise of Stock Options Cash | 15K | — |
3/15/2026 | Restricted Stock Units N/A | 9.76K | — |
| Total | 24.76K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5K
Market value
$202.2K
3/2/2026
—Completed
Units to sell
5K
Market value
$247.5K
2/2/2026
—Completed
Units to sell
5K
Market value
$232.6K
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
24.76K
Market value
$938.0K
3/18/2026
Total
Units
39.76K
Value
$1.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 5K | $202.2K | — | Completed |
2/2/2026 | 5K | $247.5K | — | Completed |
1/2/2026 | 5K | $232.6K | — | Completed |
| Planned — Approximate Date | ||||
3/18/2026 | 24.76K | $938.0K | NASDAQ | Planned |
| Total | 39.76K | $1.62M | ||